Business Wire

CO-ADTRAN

Share
Commnet Broadband transforms in-home connectivity across rural American Southwest with Adtran Intellifi®

Adtran today announced that Commnet Broadband is leveraging Intellifi® as part of its Mosaic One software-as-a-service (SaaS) solution to enhance in-home connectivity as the service provider scales across the American Southwest. The cloud-managed Wi-Fi solution will enable Commnet Broadband to deliver a seamless, always-on mesh Wi-Fi experience, boosting subscriber satisfaction while driving new efficiencies. With a strong commitment to digital inclusion, Commnet Broadband is extending its reach into more underserved rural communities, connecting them with reliable and high-quality internet services. Deploying Mosaic One for remote service activation and troubleshooting, along with Intellifi® for AI-driven insights and complete control over the home Wi-Fi environment, enables the company to efficiently manage its expansive and diverse network infrastructure.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240430732731/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Adtran’s Mosaic One and Intellifi® are helping Commnet deliver robust Wi-Fi services to underserved communities. (Photo: Business Wire)

“At Commnet Broadband, our mission is to empower underserved regions of America through reliable and personalized internet access. With Adtran’s Intellifi® solution, we’re taking our service delivery capabilities to the next level, ensuring uninterrupted and hassle-free Wi-Fi for both fiber and fixed wireless customers across our footprint,” said Scott Horne, CEO of Commnet Broadband. “One key advantage of our new system is the enhanced visibility it offers into customer premises, reducing the need for tier 1 tech support and minimizing truck rolls. Features like network-wide speed tests will enable us to analyze detailed heat maps, revealing our network’s strengths and pinpointing areas for improvement. This clear understanding of latency and speed capabilities will help us uplift the most isolated communities, ensuring we make a real and impactful difference.”

Adtran’s Intellifi®, part of the Mosaic One suite, provides a robust, cloud-hosted portal that transforms home Wi-Fi management for Commnet Broadband’s subscribers. It enhances customer support with features like Intellifi® MeshView, an operator portal that facilitates automated issue detection and remote resolution. The Intellifi® mobile app supports subscriber self-installs and offers comprehensive network control, including parental settings and device management. Mosaic One equips network engineers with predictive tools that monitor network access and identify at-risk connections. This proactive approach not only helps preemptively address issues, thereby reducing the need for on-site repairs, but it also enhances network reliability and subscriber uptime. Adtran’s Wi-Fi 6 service delivery gateways (SDGs) and mesh satellites also help ensure an exceptional Wi-Fi experience for subscribers.

“We’re excited to support Commnet Broadband as they expand their reach into more digitally excluded areas and elevate their services for all subscribers. With our Mosaic One and Intellifi® solutions, they can harness the full potential of managed Wi-Fi. That means delivering true Gigabit and multigigabit speeds and a superior level of service,” commented John Scherzinger, GM of Americas sales at Adtran. “The comprehensive telemetry, insights and user experience data that Intellifi® provides will empower Commnet Broadband to tailor services more precisely to each customer’s needs. Our virtual field technician feature can also cut operational costs, generating substantial savings per truck roll. Moreover, our technology creates new revenue opportunities, enabling Commnet Broadband to offer differentiated services that cater to the specific needs of communities, businesses and families.”

About Adtran

ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.

About Commnet Broadband

Commnet Broadband, wholly owned subsidiary of ATN International, Inc. (NASDAQ: ATNI), provides high-quality broadband communications services to carrier customers in rural America and Tribal communities, driving digital inclusion and providing access to education, work, healthcare, safety, entertainment, and community connectivity. Learn more at www.commnetbroadband.com.

Published by

ADTRAN Holdings, Inc.

www.adtran.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240430732731/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release

- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and

Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release

The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye